| Accountable Medication Management in Drug and Alcohol Services
|
SESLHDBR/077 |
|
| Acute Spinal Cord Injury of the Adult – Management and Referral Procedure
|
SESLHDPR/291 |
|
| Drug and Alcohol - Management of missed consecutive doses: Methadone and buprenorphine/buprenorphine - naloxone
|
SESLHDPR/411 |
|
| Expression and Safe Management of Expressed Breast Milk
|
SESLHDGL/081 |
|
| Guideline for Use of Complementary and Alternative Medicines in Hospital Inpatients
|
SESLHDGL/021 |
|
| Inpatient Management of Patients Admitted to SESLHD Facilities using Medicinal Cannabis Products
|
SESLHDPR/620 |
|
| Management of Complex Discharges / Escalation Guidelines
|
SESLHDGL/053 |
|
| Management of Patients Suspected of Concealing Drugs Internally transferred to St George and Prince of Wales Hospital by the Australian Federal Police Force from Customs
|
SESLHDPR/361 |
|
| Managing for Performance
|
SESLHDPR/415 |
|
| Mastitis (Lactational) Treatment
|
SESLHDPR/352 |
|
| Maternity Services Clinical Escalation Policy
|
SESLHDPD/273 |
|
| Maternity-Clinical Advice Provision and Completion of Telephone Enquiry Record
|
SESLHDPR/295 |
|
| Media and Communications Protocols
|
SESLHDPR/593 |
|
| Medical Discharge Summary
|
SESLHDPR/223 |
|
| Medical Practitioners - Medicare Provider Numbers
|
SESLHDPR/224 |
|
| Medicare Ineligible Patients – General Fees
|
SESLHDPR/425 |
|
| Medication Charts: Charting of Oral Nutrition Support
|
SESLHDPR/317 |
|
| Medication: Administration by Enrolled Nurses
|
SESLHDPD/160 |
|
| Medicine: Checking drug interactions in iPharmacy Application
|
SESLHDPD/284 |
|
| Medicine: Continuity of Management and Documentation
|
SESLHDPR/267 |
|
Medicine: Drug Formulary Policy
|
SESLHDPD/183 |
|
| Medicine: Emergency access to Oseltamivir
|
SESLHDPD/215 |
|
| Medicine: Frusemide use in Adult Chronic Heart Failure Patients
|
SESLHDPD/169 |
|
| Medicine: Management of Refrigerated Storage of Medicines and Vaccinations in Clinical Areas
|
SESLHDPR/300 |
|
| Medicine: Managing Intraoperative Medications
|
SESLHDPR/209 |
|
| Medicine: Off label use of registered medicines & use of unlicensed medicines
|
SESLHDPD/182 |
|
| Medicine: Utilising medication information from the electronic Medical Record (eMR) in the electronic Discharge Referral Summary (eDRS) for medication supply at discharge
|
SESLHDPR/327 |
|
| Meglumine Diatrizoate and Sodium Diatrizoate (Gastrografin®) in Adult Adhesional Small Bowel Obstruction
|
SESLHDPR/570 |
|
| Micafungin for prevention and treatment of fungal infections in critically ill patients
|
SESLHDPR/630 |
|
| Mobile Phones - provisioning and use of
|
SESLHDPD/300 |
|
| Mobile Services - Procedure
|
SESLHDPR/645 |
|
| Motor vehicle policy
|
SESLHDPD/285 |
Under Review |
| Opioid Withdrawal in Patients on Long Term Opioid Medications
|
SESLHDPR/603 |
|
| Postoperative Mobilisation Guideline
|
SESLHDGL/061 |
|
| Scabies - Management of
|
SESLHDPR/363 |
|
| Sterilisation: Designation of Reusable Medical Devices (RMDs) to a Product Family
|
SESLHDPR/627 |
|
| Stockley Interactions Alerts Display Filter
|
SESLHD/BR 003 |
|
| Use of Generic Medications
|
SESLHDPD/320 |
|
| Use of MOSAIQ - Cancer Services Information System for Electronic Medication Management
|
SESLHDPR/280 |
Under Review |
| Work Health and Safety - Hazardous Manual Task Risk Management Procedure
|
SESLHDPR/315 |
|
| Work Health and Safety - Measurement and Evaluation of Work Health and Safety Performance Procedure
|
SESLHDPR/395 |
|
Work Health and Safety - Safe Handling and Management of Monoclonal Antibodies Procedure
|
SESLHDPR/368 |
|
